RetinaScope: hand-held camera for detecting eye diseases
People with diabetes often experience eye problems that can lead to blindness. They are advised to have their eyes checked regularly, but that is often a time-consuming and expensive procedure. Together with TNO, technology startup RetinaScope has developed an advanced portable camera that is inexpensive and easy to handle, making it cheaper and more convenient to carry out frequent eye tests.
Learn more about RetinaScope
The aim of this venture is to equip GP practices with the camera, doing away with the need for special visits to a hospital or clinic. The camera’s simple-to-use controls mean that it can be operated by the GP’s assistant. Diagnostic films can also be made at pharmacies and opticians, or even as a mobile service at the patient’s home.
GPs have the necessary understanding to assess the resulting images of the retina, but this can also be done remotely in the cloud by a specialist. A further advance might take the form of fully automated analysis by artificial intelligence (AI) software. RetinaScope is collaborating with a number of specialised companies that have developed this retina photography software. The camera will soon be easy to link to this software, thereby removing an important barrier for patients when it comes to having their eyes checked.
Support from TNO
RetinaScope has placed the camera’s manufacture in the hands of Taiwanese firm Dino-Lite, a supplier of digital microscopes. TNO was approached to provide the design thanks to its in-depth expertise in the field of optical technologies. In addition to furnishing this knowledge, TNO has provided support in the fields of industrial design, market exploration and finance. Innovatiefonds Noord-Holland, an Amsterdam-based platform specialised in funding for innovative companies, granted a convertible further development loan in March. This should be enough to ensure completion of the design by the end of this year, when production can begin.
Preventing unnecessary diseases
The camera is expected to make a vital contribution to the fight against blindness. Existing screening methods entail a good deal of time and effort on the part of the patient. As a result, patients often skip frequent checks and are therefore at greater risk of discovering an eye disease when it is too late. Timely detection and treatment can minimise or even prevent damage to the eye.
The camera is well-suited to diagnosing common eye diseases such as diabetic retinopathy (retinal damage), glaucoma (a form of cataract) and macular degeneration (leading to impaired/blurred vision).
TNO launches digital health spin-off AIKON Health for wearable monitoring
TNO launches digital health spin-off AIKON Health for wearable monitoring.
TNO signs Declaration of Amsterdam for inclusive and diverse workplace
Today TNO signs the Declaration of Amsterdam. This is a declaration of intent by Workplace Pride, the international foundation for LGBTQIA+ inclusion at work. With this, TNO underlines the importance, both moral and practical, of an inclusive workplace and organization. More inclusion also reduces dropout and turnover of innovative talent.
TNO publishes fully integrated Annual Report 2022
TNO's Annual Report 2022 is published. For the first time, it concerns a fully integrated annual report, in which sustainability is fully incorporated into the general annual report.
Public Private Partnership supports intestinal health in early life
Public Private Partnership Fontanelle works on the solutions that contribute to long-term effects on (gut) health through the development of an integrated approach of in vitro, ex vivo and AI models to test the potential health benefits of specialised nutrition for infants and young piglets.
WHO launches new package to measure early development of children up to 36 months
Today the World Health Organization (WHO) launched the Global Scales for Early Development (GSED). TNO was part of the team that developed the GSED package. With the Developmental score (D-score), TNO provided the backbone for the GSED.